日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms

乳腺导管增生发展为乳腺癌的复杂路径:非典型病变恶性肿瘤风险升高

Gheban, Bogdan-Alexandru; Mocan, Lavinia Patricia; Boșca, Adina Bianca; Suflețel, Rada Teodora; Dronca, Eleonora; Jianu, Mihaela Elena; Crivii, Carmen; Pașcalău, Tudor Cristian; Onofrei, Mădălin Mihai; Moise-Crintea, Andreea; Șovrea, Alina Simona

Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial

血浆置换和放射治疗可使免疫疗法难治性黑色素瘤重新敏感:一项 I 期试验

Orme, Jacob J; Zhang, Henan; Lingamaneni, Prashanth; Kim, Yohan; Lavoie, Roxane; Dorr, Maddy; Dizona, Paul; Hirdler, Jacob; Bering, Elizabeth A; Gicobi, Joanina K; Hsu, Michelle; Dale, Heather; Childs, Daniel S; Kottschade, Lisa A; McWilliams, Robert R; Block, Matthew S; Mansfield, Aaron S; Markovic, Svetomir N; Olivier, Ken; Owen, Dawn; Lester, Scott; Ma, Daniel; Dronca, Roxana S; Dong, Haidong; Lucien, Fabrice; Packard, Annie T; Winters, Jeffrey L; Park, Sean S

Immunotherapy and Radiation for Clinical Perineural Invasion in Cutaneous Squamous Cell Carcinoma

免疫疗法和放射疗法治疗皮肤鳞状细胞癌的临床神经周围浸润

Morecroft, Renee A; Phillipps, Jordan S; Gou, Lang; Bhatt, Alok A; Kim, Sungjune; Mohammadi, Homan; Dronca, Roxana S; Doonan, Bently; Chen, Ruqin; Zhao, Yujie; Kang, Hye Seon; Li, Shenduo; Janus, Jeffrey R; Pirgousis, Phillip; Patel, Samip; Okuyemi, Oluwafunmilola T; Singer, Elisha M; Tolaymat, Leila M; Wysong, Ashley; Degesys, Catherine A; Barbosa, Naiara; Holtzman, Adam L

Non-Drug and Non-Invasive Therapeutic Options in Alzheimer's Disease

阿尔茨海默病非药物和非侵入性治疗方案

Șovrea, Alina Simona; Boșca, Adina Bianca; Dronca, Eleonora; Constantin, Anne-Marie; Crintea, Andreea; Suflețel, Rada; Ștefan, Roxana Adelina; Ștefan, Paul Andrei; Onofrei, Mădălin Mihai; Tschall, Christoph; Crivii, Carmen-Bianca

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial

新辅助治疗方案:cobimetinib 和 atezolizumab 联合或不联合 vemurafenib 用于高危可手术 III 期黑色素瘤:II 期 NeoACTIVATE 试验

Tina J Hieken ,Garth D Nelson ,Thomas J Flotte ,Eric P Grewal ,Jun Chen ,Robert R McWilliams ,Lisa A Kottschade ,Lu Yang ,Evidio Domingo-Musibay ,Roxana S Dronca ,Yiyi Yan ,Svetomir N Markovic ,Anastasios Dimou ,Heather N Montane ,Courtney L Erskine ,Mara A Piltin ,Daniel L Price ,Samir S Khariwala ,Jane Hui ,Carrie A Strand ,Susan M Harrington ,Vera J Suman ,Haidong Dong ,Matthew S Block

Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1

一种靶向PD-L1的实体瘤CAR-T细胞疗法,可同时攻击肿瘤细胞和免疫抑制细胞。

Luo, Yan; Gadd, Martha E; Qie, Yaqing; Otamendi-Lopez, Andrea; Sanchez-Garavito, Jesus E; Brooks, Mieu M; Ulloa Navas, Maria J; Hundal, Tanya; Li, Shuhua; Jones, Vanessa K; Lou, Yanyan; Patel, Tushar; Dronca, Roxana; Kharfan-Dabaja, Mohamed A; Dong, Haidong; Quinones-Hinojosa, Alfredo; Qin, Hong

Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting

在三级医院接受治疗的老年黑色素瘤患者中,靶向治疗的疗效和毒性的真实世界证据

Stoff, Ronen; Markovic, Svetomir N; McWilliams, Robert R; Kottschade, Lisa A; Montane, Heather N; Dimou, Anastasios; Dudek, Arkadiusz Z; Tan, Winston; Dronca, Roxana S; Seetharam, Mahesh; Chen, Ruqin; Block, Matthew S

Targeting chronic lymphocytic leukemia with B-cell activating factor receptor CAR T cells

利用 B 细胞活化因子受体 CAR-T 细胞治疗慢性淋巴细胞白血病

Yaqing Qie, Martha E Gadd, Qing Shao, Tommy To, Andrew Liu, Shuhua Li, Rocio Rivera-Valentin, Farah Yassine, Hemant S Murthy, Roxana Dronca, Mohamed A Kharfan-Dabaja, Hong Qin, Yan Luo

Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies

针对 B 细胞淋巴系统恶性肿瘤的新型 BAFF-R CAR-T 疗法的转化开发

Yan Luo #, Yaqing Qie #, Martha E Gadd, Alak Manna, Rocio Rivera-Valentin, Tommy To, Shuhua Li, Farah Yassine, Hemant S Murthy, Roxana Dronca, Mohamed A Kharfan-Dabaja, Hong Qin

A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses

一项I期溶瘤病毒试验,采用表达人干扰素β和酪氨酸酶相关蛋白1的水疱性口炎病毒,通过瘤内注射和静脉注射治疗葡萄膜黑色素瘤:安全性、有效性和T细胞反应

Smith, Katherine E R; Peng, Kah-Whye; Pulido, Jose S; Weisbrod, Adam J; Strand, Carrie A; Allred, Jacob B; Newsom, Alysha N; Zhang, Lianwen; Packiriswamy, Nandakumar; Kottke, Timothy; Tonne, Jason M; Moore, Madelyn; Montane, Heather N; Kottschade, Lisa A; McWilliams, Robert R; Dudek, Arkadiusz Z; Yan, Yiyi; Dimou, Anastasios; Markovic, Svetomir N; Federspiel, Mark J; Vile, Richard G; Dronca, Roxana S; Block, Matthew S